---
$id: https://graph.org.ai/products/commodity/51172314
$type: Product
source: UNSPSC
code: "51172314"
title: "Pralidoxime"
class: "51172300"
classTitle: "Antidotes and emetics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pralidoxime

**UNSPSC Code**: 51172314
**Class**: [Antidotes and emetics](Antidotes and emetics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholinergic agonist with the molecular formula C7H9N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P7MU9UTP52, chemically known as pyridinium, 2-((hydroxyimino)methyl)-1-methyl-, iodide but generally known as pralidoxime, which bears US NIH Compound Identifier 5353894. European Medicines Agency schedules Pralidoxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04002MIG. World Health Organization schedules pralidoxime in its Anatomical Therapeutic Chemical (ATC) Classification. PRALIDOXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, PRALIDOXIME remains the US FDA Preferred Term for this commodity. Pralidoxime bears US NLM identifiers UMLS ID C0071808 and NCI Concept Code C78131. SMILES: O=[NH]/C=C1/N(CCCC1)C.

